Penile Cancer
📧 Sign up to get email alerts when something new happens for Penile Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study assessing the combination of nivolumab, ipilimumab, and cabozantinib for various rare ge…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination [NA]
Clinical trial update on an education- and technology-based program to increase HPV vaccination uptake among parents; the study is currently…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: DEfeating PEnile CAncer-2 [NA]
An ongoing clinical trial at University Hospital Tuebingen is recruiting participants for penile cancer.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of an EGFR-directed antibody-drug conjugate with a PD-1 inhibitor as neoadjuvant therapy…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma [Phase 1]
Phase 1 trial evaluating MRG003 plus HX008 as first-line therapy for EGFR-positive locally advanced or metastatic penile cancer. The study i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer [Phase 2]
A Phase 2 clinical trial update investigating Becotatug Vedotin combined with Pucotenlimab for EGFR-positive advanced penile cancer, current…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions [NA]
The study tests whether a transtheoretical model-based educational intervention improves HPV knowledge, health beliefs, and vaccination inte…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial [NA]
A clinical trial update describing the IMPACT HPV trial assessing interpersonal communication training and vaccination workflow training in …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer
The clinical trial evaluating patient experience and needs for invasive inguinal lymph node procedures in penile cancer is currently suspend…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers [Phase 1, Phase 2]
Clinical trial update for an E7 TCR-T cell therapy being studied in locoregionally advanced HPV-associated cancers. Recruitment is ongoing f…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers [Phase 2]
Phase 2 study of E7-targeted TCR-T cell immunotherapy for HPV-associated cancers is currently recruiting. The sponsor is Christian Hinrichs …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region. [NA]
A clinical trial is testing an HPV primary prevention intervention to improve HPV vaccination uptake among middle and high school students i…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors [Phase 2]
Status update on a Phase 2 trial of nivolumab plus ipilimumab for advanced rare genitourinary tumors; the study is currently active but not …
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Lymphedema After Urologic Surgery
An update on a clinical trial examining lymphedema after urologic cancer surgery shows the study is currently recruiting for patients with u…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer [Phase 2]
Phase 2 clinical trial evaluating carboplatin/paclitaxel in combination with pembrolizumab for locoregionally advanced penile cancer; curren…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination [NA]
This clinical trial is evaluating whether sending reminders about HPV vaccination via adolescents' preferred communication methods increases…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Ivonescimab in the Treatment of Multiple Advanced Tumors [Phase 2]
An update indicating Ivonescimab is being studied in a Phase 2 trial for multiple advanced tumors and is currently recruiting. The trial cov…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial [NA]
A clinical trial update describes TweenVax, an Emory University vaccine to improve adolescent HPV vaccination, currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males [Phase 3]
Phase III trial evaluating the efficacy, immunogenicity, and safety of a recombinant HPV9-valent vaccine in Chinese males for prevention of …
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer [Phase 1]
A first-in-human Phase 1 trial of CC-3, a CD276xCD3 bispecific antibody, is recruiting for colorectal cancer with listed indications includi…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer [NA]
The entry reports on a clinical trial evaluating video-endoscopic radical inguinal lymphadenectomy for penile cancer. The study status is ac…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer [Phase 2]
A Phase 2 clinical trial is evaluating a TIP regimen combined with Triplizumab as neoadjuvant therapy for locally advanced penile cancer and…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]
Clinical trial update describing the use of hybrid MRI-PET molecular imaging to characterize metastatic penile cancer.
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors [NA]
This clinical trial update describes a provider-focused intervention to maximize HPV vaccine uptake among young cancer survivors and notes t…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors [Phase 2]
Phase II, multi-cohort, single-arm trial evaluating a triplet regimen of albumin-bound paclitaxel, ifosfamide, and cisplatin in rare advance…